Загрузка...
Crossing the Rubicon: A fine line between waiting and vaccinating adolescents against COVID-19
Several countries with advanced adult COVID-19 immunisation programmes have already started vaccinating adolescents with an mRNA vaccine that recently received emergency use authorisation for 12–15 year-olds. The decision to vaccinate adolescents remains highly divisive among parents, clinicians, po...
Сохранить в:
| Опубликовано в: : | J Infect |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8294773/ https://ncbi.nlm.nih.gov/pubmed/34302866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jinf.2021.07.015 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|